Cannabismarketcap

cbdMD Inc Stock Forecast & Price Prediction 2026-2027

Algorithmic price targets and analysis for YCBD based on fundamentals, valuation multiples, and historical data.

$0.37+0.27%
Bullish

Price Target Summary

Bear Case
$0.31
-15.5% from current
Base Case
$5.14
+1284.9% from current
Bull Case
$9.25
+2392.7% from current

Technical Outlook

52-Week Range Analysis

$0.33$2.56
Current: $0.37
Support Level
$0.55
Resistance Level
$2.34
From 52W High
-85.5%
From 52W Low
+12.4%

Fundamental Analysis

Revenue Growth Projection

Year 1 Projected
$23.0M
Year 2 Projected
$24.9M
Year 3 Projected
$26.4M

Based on +10.0% YoY growth, tapered 20% per year in outer projections.

Valuation vs Peers

Current P/S
0.20x
Sector Median P/S
2.5x
Assessment
Undervalued vs sector

Cash Position

Cash on Hand
$2.1M
Total Debt
N/A
Cash Runway
11 mo

Key Metrics

Current Price$0.37
Market Cap$4.2M
P/S Ratio0.20x
Revenue (TTM)$20.9M
Revenue Growth (YoY)+10.0%
Gross Margin57.7%
Cash on Hand$2.1M
Total DebtN/A
52W High$2.56
52W Low$0.33

Signal Breakdown

Overall Signal: Bullish
  • Strong revenue growth above 10% YoY
  • Healthy gross margins above 40%
  • Trading more than 50% below 52-week high
  • P/S ratio below sector median suggests upside

Risk Factors

  • Limited cash runway: approximately 11 months of cash remaining at current burn rate.
  • Penny stock status (below $1.00) carries heightened volatility and delisting risk.

Analyst Summary

cbdMD Inc (YCBD) is a CBD and hemp company with growing revenue and a market capitalization of $4.2M. Based on trailing revenue of $20.9M and a P/S ratio of 0.20x, the stock appears undervalued relative to the sector median of 2.5x. Our algorithmic base-case price target of $5.14 implies upside of 1284.9% from current levels. The overall signal is bullish, supported by positive fundamental indicators. Investors should weigh the 2 identified risk factors before making any investment decision.

Frequently Asked Questions

What is the price target for YCBD?+
Our algorithmic base-case price target for cbdMD Inc (YCBD) is $5.14, with a bear case of $0.31 and a bull case of $9.25. These targets are derived from sector-average and premium P/S multiples applied to projected revenue.
Is YCBD a buy right now?+
Based on our algorithmic analysis, YCBD currently carries a bullish signal. Strong revenue growth above 10% YoY. Healthy gross margins above 40%. This is not a buy or sell recommendation — always do your own due diligence.
What is the revenue forecast for cbdMD Inc?+
Based on the current year-over-year growth rate of +10.0%, we project YCBD revenue at $23.0M in Year 1, $24.9M in Year 2, and $26.4M in Year 3. Growth rates are tapered in outer years.
What are the risks of investing in YCBD?+
Limited cash runway: approximately 11 months of cash remaining at current burn rate. Penny stock status (below $1.00) carries heightened volatility and delisting risk.
How does YCBD valuation compare to the cannabis sector?+
YCBD has a trailing P/S ratio of 0.20x compared to the cannabis sector median of 2.5x. The stock undervalued vs sector.

Important Disclaimer

This is not financial advice. Forecasts are algorithmic projections based on historical data and should not be used as the sole basis for investment decisions. Past performance does not guarantee future results. Cannabis stocks carry significant risk including regulatory, market, and operational risks. Always consult with a qualified financial advisor before making investment decisions. Cannabismarketcap does not recommend buying, selling, or holding any security.

← Back to YCBD OverviewAll Cannabis Stocks